Chemical inhibitors of epsin2 include a variety of compounds that target different aspects of the endocytic pathway in which epsin2 is a key player. Pitstop 2 directly inhibits clathrin, a protein that forms a polyhedral lattice around vesicles as they bud from the plasma membrane, which is a process facilitated by epsin2. By binding to the terminal domain of clathrin, Pitstop 2 disrupts the formation of clathrin-coated pits, thus interfering with epsin2's ability to promote endocytosis. Similarly, Chlorpromazine has been shown to disrupt clathrin-mediated endocytosis by preventing the assembly of clathrin at the plasma membrane, which would likely inhibit epsin2 function as it is involved in cargo selection during the formation of clathrin-coated vesicles. Tyrphostin A23 also targets this pathway by inhibiting the assembly of clathrin-coated pits, thereby reducing the functionality of epsin2 in vesicle formation and trafficking.
In addition to compounds that target clathrin directly, several inhibitors affect dynamin, a GTPase essential for the scission of clathrin-coated vesicles from the plasma membrane. Dynasore, Dyngo-4a, and MiTMAB are inhibitors that prevent dynamin from executing the GTP hydrolysis required for vesicle scission, which is a critical step in which epsin2 is involved. These compounds, therefore, indirectly inhibit epsin2 by blocking the final stage of clathrin-mediated endocytosis where epsin2 is active. Ocaperidone, while not a classical endocytosis inhibitor, interacts with components of the clathrin pathway, suggesting a potential to inhibit epsin2's role in this process. Ciliobrevin D, by inhibiting dynein, indirectly affects epsin2 as it may impede the transport of vesicles within the cell, thus altering the intracellular trafficking that epsin2 might regulate. EGA and Endosidin2 disrupt endosomal trafficking, which can limit epsin2's ability to sort endosomal cargo, thereby indirectly inhibiting its function. Lastly, Genistein's inhibition of tyrosine kinases can lead to a decrease in epsin2's role in receptor-mediated endocytosis, since phosphorylation events are often critical for the internalization of cargo molecules.
VER TAMBIÉN ....
| Nombre del producto | NÚMERO DE CAS # | Número de catálogo | Cantidad | Precio | MENCIONES | Clasificación |
|---|---|---|---|---|---|---|
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | ¥4062.00 | ||
Pitstop 2 inhibe la clatrina uniéndose al dominio terminal, reduciendo potencialmente la endocitosis mediada por epsina2. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | ¥982.00 | 44 | |
Dynasore inhibe la actividad GTPasa de dynamin, que es necesaria para la escisión de vesículas, un proceso que facilita epsin2. | ||||||
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | ¥2821.00 | ||
Hydroxy-Dynasore inhibe la dinamina, lo que puede impedir que la epsina2 medie en el proceso de endocitosis. | ||||||
Dynamin Inhibitor II | 1119-97-7 | sc-203931 sc-203931A sc-203931B sc-203931C | 5 g 250 g 500 g 1 kg | ¥519.00 ¥925.00 ¥1376.00 ¥2189.00 | ||
El inhibidor de la dinamina II bloquea la escisión de vesículas y potencialmente el papel de la epsina2 en la endocitosis. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | ¥677.00 ¥1218.00 | 21 | |
La clorpromazina puede interrumpir la endocitosis mediada por clatrina, lo que puede inhibir funcionalmente la epsina2. | ||||||
Ciliobrevin D | 1370554-01-0 | sc-507482 | 10 mg | ¥4659.00 | ||
La ciliobrevina D inhibe la dineína, que puede inhibir indirectamente la epsina2 al interrumpir el transporte intracelular de vesículas. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | ¥293.00 ¥1038.00 ¥1354.00 ¥3497.00 ¥5641.00 ¥10244.00 ¥20545.00 | 46 | |
La genisteína inhibe las tirosina quinasas, lo que puede reducir el papel de la epsina2 en la endocitosis mediada por receptores. | ||||||
Tyrphostin A23 | 118409-57-7 | sc-3554 | 10 mg | ¥1241.00 | 13 | |
La tirfosfostina A23 inhibe la endocitosis dependiente de clatrina, disminuyendo potencialmente la función endocítica de la epsina2. | ||||||